{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:14:22Z","timestamp":1740183262466,"version":"3.37.3"},"reference-count":40,"publisher":"Maad Rayan Publishing Company","issue":"9","content-domain":{"domain":["journalaim.com"],"crossmark-restriction":false},"short-container-title":["Arch Iran Med"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:p>Born in 1940 in Rasht, Iran, Dr. Farrokh Modabber earned his B.A. in Bacteriology and Ph.D. in Microbiology from University of California, Los Angeles (UCLA). He joined the Harvard Medical School as a fellow before transitioning to a faculty role at Harvard School of Public Health (HSPH) and played a pivotal role in advancing Cellular Immunology. In the early 1970s, he returned to Iran as an Associate Professor at Pahlavi University in Shiraz. Subsequently, he rejoined HSPH before embarking on a tenure at Tehran University. As the head of the Pathobiology Department at Tehran University School of Public Health, he initiated the Tehran\/Harvard joint M.Sc. program in Immunology, which played a crucial role in shaping the careers of numerous Iranian immunologists over the following decades. Dr. Modabber went on to hold esteemed positions such as Director General of the Pasteur Institute of Iran, visiting immunology lecturer at various universities, Coordinator of Research Capability Strengthening of WHO\u2019s Special Program for Research and Training in Tropical Diseases (TDR), Director of the Infectious Disease Research Institute (IDRI), and Senior Advisor of Drugs for Neglected Diseases initiative (DNDi), to name a few. This article highlights Dr. Modabber\u2019s impactful career, focusing on his efforts to combat global leishmaniasis.<\/jats:p>","DOI":"10.34172\/aim.28959","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T10:58:03Z","timestamp":1727866683000},"page":"530-537","update-policy":"https:\/\/doi.org\/10.34172\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Commemoration of Dr. Farrokh Modabber: An Iranian Pioneer of Cellular Immunology, and Leishmaniases Vaccine Research in Iran and the World"],"prefix":"10.34172","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-415X","authenticated-orcid":true,"given":"Fariborz","family":"Bahrami","sequence":"first","affiliation":[{"name":"Department of Immunology, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1997-517X","authenticated-orcid":true,"given":"Ehsan","family":"Mostafavi","sequence":"additional","affiliation":[{"name":"Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Epidemiology and Biostatistics, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20123","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"R1","unstructured":"Hosseini F, Nikbin B, Jaffari R. History of Immunology and Allergy in Iran and the World (Chapter 10). Tehran: Ebn-e-Sina Press; 2018. p. 273-86. [Persian]."},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1126\/science.159.3817.884"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1126\/science.170.3962.1102"},{"key":"R4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.116.4.915","article-title":"Characterization of T and B antigen-binding cells for beta-galactosidase I beta-galactosidase-binding cells in the thymus and spleen of normal mice","volume":"116","author":"Swain S","year":"1976","journal-title":"J Immunol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.4049\/jimmunol.116.4.923","article-title":"Characterization of T and B antigen-binding cells for beta-galactosidase II T antigen-binding cells","volume":"116","author":"Swain S","year":"1976","journal-title":"J Immunol"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1159\/000230576"},{"key":"R7","first-page":"366","article-title":"Tears as carriers of antibodies II","volume":"1","author":"Modabber F","year":"1969","journal-title":"Ann Ophthalmol"},{"key":"R8","first-page":"112","article-title":"Presence of antibodies cytophilic to corneal epithelium in rabbit tears","volume":"7","author":"Modabber F","year":"1969","journal-title":"Invest Ophthalmol"},{"key":"R9","first-page":"618","article-title":"Immunity to chlamydial infections of the eye 3 Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis","volume":"111","author":"Watson RR","year":"1973","journal-title":"J Immunol"},{"key":"R10","first-page":"929","article-title":"The effect of cyclophosphamide on the recovery from a local chlamydial infection Guinea-pig inclusion conjunctivitis (GPIC)","volume":"30","author":"Modabber F","year":"1976","journal-title":"Immunology"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1979.tb00870.x"},{"key":"R12","first-page":"597","article-title":"Histocompatibility antigens in patients with leprosy from Azarbaijan, Iran","volume":"47","author":"Mohagheghpour N","year":"1979","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1128\/iai.26.2.611-614.1979"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1128\/iai.37.3.895-902.1982"},{"key":"R15","first-page":"493","article-title":"Studies on visceral Leishmania tropica infection in BALB\/c mice I Clinical features and cellular changes","volume":"46","author":"Djoko-Tamnou J","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"R16","first-page":"145","article-title":"Preliminary survey of trachoma in 11 selected villages in Khouzestan and Fars","volume":"7","author":"Modabber F","year":"1978","journal-title":"Iran J Public Health"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(81)90430-2"},{"key":"R18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4049\/jimmunol.131.3.1492","article-title":"Lack of general immunosuppression during visceral Leishmania tropica infection in BALB\/c mice: augmented antibody response to thymus-independent antigens and polyclonal activation","volume":"131","author":"Colle JH","year":"1983","journal-title":"J Immunol"},{"key":"R19","first-page":"53","article-title":"Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy","volume":"47","author":"Bahr GM","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(82)90375-3"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(83)90052-4"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(84)90068-7"},{"key":"R23","first-page":"178","article-title":"Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells","volume":"57","author":"Bahr GM","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1159\/000233576"},{"key":"R25","first-page":"1","article-title":"Increased myelopoiesis during Leishmania major infection in mice: generation of \u2018safe targets\u2019, a possible way to evade the effector immune mechanism","volume":"64","author":"Mirkovich AM","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.085"},{"key":"R27","unstructured":"Mostafavi E, Haghdoost A, Yavari P, Chaman R, Mesdaghinia A, Enayatrad M. Dr. Abolhassan Nadim, founder of modern epidemiology in Iran. Iran J Epidemiol 2018;13(4):264-72. [Persian]."},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.02.015"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081x(96)00071-5"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(98)00220-5"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(98)09552-x"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.34172\/aim.2023.09"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(02)00458-9"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1179\/146532806x152890"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2007.08.006"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90083-3"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.058"},{"key":"R38","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"Asilian A","year":"2003","journal-title":"Bull World Health Organ"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1128\/iai.70.8.4215-4225.2002"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)62050-8"}],"container-title":["Archives of Iranian Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalaim.com\/PDF\/aim-27-530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journalaim.com\/PDF\/aim-27-530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:17:28Z","timestamp":1729747048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalaim.com\/Article\/aim-28959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,1]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.34172\/aim.28959","relation":{},"ISSN":["1029-2977","1735-3947"],"issn-type":[{"type":"print","value":"1029-2977"},{"type":"electronic","value":"1735-3947"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"Academy of Medical Sciences of I.R. Iran","name":"journal_owner","label":"Journal Owner"},{"value":"Academy of Medical Sciences of I.R. Iran","name":"journal_publisher","label":"Journal Publisher"},{"value":"2024-02-19","order":1,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}